You are currently viewing Everolimus vs sirilmus eluting stents for bifurcation

Everolimus vs sirilmus eluting stents for bifurcation

EBC - ON DEMAND

Everolimus vs sirilmus eluting stents for bifurcation

European Bifurcation Club 2011, EBC 2011 – Lisbon, Portugal

HOT NEWS SESSION

Everolimus vs sirilmus eluting stents for bifurcation

Author: Manuel Pan, MD, Reina Sofia Hospital, Sevilla, Spain

 

BACKGROUND

  • Simple approach or provisional SB stenting is the current preferred strategy for the percutaneous treatment of bifurcation lesions.
  • The outcome of patients treated with this strategy may be influenced by the type of drug eluting stent implanted at main vessel.
  • The metal platform of the stent is deformed when SB is dilated; the polymer may be damaged; and the drug may be unevenly distributed.

AIM

To compare the efficacy of sirolimus- and everolimus-eluting stents in patients with bifurcation lesions treated by provisional side branch stenting.

CONCLUSION

In patients with bifurcation lesions, no significant differences in clinical outcome at 1-year follow-up were observed between sirolimus and everolimus-eluting stent groups.

 

Download here

Leave a Reply